When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia

The measurement of minimal residual disease (MRD) in pediatric acute lymphoblastic leukemia (ALL) has become the most important prognostic tool of, and the backbone to, upfront risk stratification. While MRD assessment is the standard of care for assessing response and predicting outcomes for pediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamble, Adam, Phelan, Rachel, Burke, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532574/
https://www.ncbi.nlm.nih.gov/pubmed/28686179
http://dx.doi.org/10.3390/jcm6070066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532574/
https://www.ncbi.nlm.nih.gov/pubmed/28686179
http://dx.doi.org/10.3390/jcm6070066

Ejemplares similares